IL-1 alpha

IL-1 alpha 분자 정보

영어 이름Interleukin-1 alpha시판 약물 수1
임상 약물 수11표적 별명Interleukin-1 Alpha,IL1A,IL1F1,IL-1 alpha,Interleukin 1 Alpha,Hematopoietin-1,Pro-Interleukin-1-Alpha,Preinterleukin 1 Alpha,IL1-ALPHA,IL-1A,IL1,Interleukin-1alpha
최고 연구 개발 단계Approved
영어 이름Interleukin-1 alpha
표적 별명Interleukin-1 Alpha,IL1A,IL1F1,IL-1 alpha,Interleukin 1 Alpha,Hematopoietin-1,Pro-Interleukin-1-Alpha,Preinterleukin 1 Alpha,IL1-ALPHA,IL-1A,IL1,Interleukin-1alpha
시판 약물 수1
임상 약물 수11
최고 연구 개발 단계Approved

IL-1 alpha 제품 목록

  • 속성

    Protein (4)

  • 제품 라이브러리

    온라인 (4)

  • Human (2)Mouse (2)

  • 태그

    His Tag (2)His Tag & Avi Tag (2)

  • 마커

    Unconjugated (2)Biotin-labeled (2)

IL-1 alpha분자 배경

Interleukin-1 alpha (IL1a) is also known as IL-1A, IL1, IL1-ALPHA,IL1F1,and is a cytokine of the interleukin-1 family. IL1a possesses a wide spectrum of metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. It binds to the interleukin-1 receptor. IL-1α is constitutively produced by epithelial cells. It is found in substantial amounts in normal human epidermis and is distributed in a 1:1 ratio between living epidermal cells and stratum corneum.The constitutive production of large amounts of IL-1α precursor by healthy epidermal keratinocytes interfere with the important role of IL-1α in immune responses, assuming skin as a barrier, which prevents the entry of pathogenic microorganisms into the body. In vitro, IL-1α possesses biological effect on cells in the picomolar to femtomolar range. In vivo, Shortly after an onset of an infection into organism, IL-1α activates a set of immune system response processes.

IL-1 alpha분자 별명

IL1A,IL-1 ALPHA,IL1F1,IL1α

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Tadekinig alfar-hIL-18BP; IL-18BPPhase 3 ClinicalAb2 Bio LtdAutoimmune Lymphoproliferative Syndrome; Lymphohistiocytosis, Hemophagocytic; Macrophage Activation Syndrome
상세
LutikizumabABT-981Phase 3 ClinicalAbbvie IncColitis, Ulcerative; Crohn Disease; Dermatitis, Atopic; Hidradenitis Suppurativa; Osteoarthritis; Osteoarthritis, Knee
상세
KPL-387KPL-387Phase 3 ClinicalKiniksa Pharmaceuticals LtdHeart Diseases; Pericarditis
상세
BermekimabT2-18C3; RA-18C3; CV-18C3; CA-18C3; MABP-1; MABp1; JNJ-77474462; MAB-p1Phase 2 ClinicalXbiotech IncAcne Vulgaris; Colorectal Neoplasms; Dermatitis, Atopic; Diabetes Mellitus, Type 2; Digestive System Diseases; Eczema; Hematologic Neoplasms; Hidradenitis Suppurativa; Neoplasms; Psoriasis; Pyoderma Gangrenosum; Scleroderma, Systemic
상세
ABBV-9832ABBV-9832Phase 2 ClinicalAbbvie IncArthritis, Rheumatoid
상세
ABBV-166ABBV-166Phase 2 ClinicalAbbvie IncArthritis, Psoriatic; Crohn Disease
상세
AC-701AC-701Phase 2 ClinicalTwi Pharmaceuticals IncExanthema; Rosacea
상세
VilamakitugXB-2001Phase 2 ClinicalXbiotech IncArthritis, Rheumatoid; Axial Spondyloarthritis; Pancreatic Neoplasms; Rheumatic Diseases
상세
CAN-10CAN-10Phase 1 ClinicalLund University FoundationMyocarditis; Plaque psoriasis; Scleroderma, Systemic
상세
GenSci-161GenSci-161Phase 1 ClinicalChangchun GeneScience Pharmaceuticals Co LtdEndometriosis; Hidradenitis Suppurativa
상세
Interleukin-1-alpha targeting antibody (XBiotech)Phase 1 ClinicalXbiotech Inc
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
RilonaceptKPL-914; RGN-303ApprovedRegeneron Pharmaceuticals IncArcalyst, 炎朵United StatesCryopyrin-Associated Periodic SyndromesKiniksa Pharmaceuticals Ltd2008-02-27Anemia; Arthritis, Juvenile; Atherosclerosis; Coronary Artery Disease; Cryopyrin-Associated Periodic Syndromes; Deficiency of interleukin-1 receptor antagonist; Diabetes Mellitus, Type 1; Familial Mediterranean Fever; Genetic Diseases, Inborn; Gout; Hearing Loss, Sensorineural; Inflammation; Muckle-Wells Syndrome (MWS); Pericarditis; Renal Insufficiency, Chronic; Sarcoidosis; Schnitzler Syndrome; Scleroderma, Diffuse; Scleroderma, Systemic; Still's Disease, Adult-Onset; Urticaria; Vascular Diseases
상세
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호